Double maintains 4 strategies that include ANIP - ANI Pharmaceuticals, Inc.
Current Value
$59.001 Year Return
Current Value
$59.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -21.22% | $21.80B | +11.92% | 1.14% |
STG | -18.90% | $35.60M | -18.31% | 0.00% |
DAVA | -17.55% | $1.53B | -49.73% | 0.00% |
FTNT | -15.03% | $84.29B | +56.53% | 0.00% |
UUU | -13.80% | $4.91M | +50.71% | 0.00% |
FATBB | -12.63% | $65.17M | -20.18% | 15.01% |
EEX | -11.36% | $899.22M | -34.08% | 0.68% |
XEL | -11.33% | $39.28B | +15.91% | 3.18% |
HUSA | -10.57% | $22.27M | -3.40% | 0.00% |
PRPO | -8.69% | $10.94M | +11.01% | 0.00% |
DT | -7.47% | $18.67B | +19.75% | 0.00% |
SRRK | -7.21% | $3.52B | +138.62% | 0.00% |
ABEV | -7.17% | $29.41B | -26.95% | 5.71% |
EXAS | -6.98% | $9.36B | -17.19% | 0.00% |
SUZ | -6.42% | $12.75B | +0.82% | 0.00% |
PULM | -6.37% | $27.36M | +307.07% | 0.00% |
CWAN | -6.26% | $6.09B | +39.38% | 0.00% |
CQP | -6.24% | $30.17B | +21.01% | 5.22% |
CME | -6.17% | $90.13B | +18.52% | 4.18% |
CPSH | -5.99% | $28.91M | -18.44% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
AGZD | -0.06% | $135.16M | 0.23% |
CQQQ | -0.17% | $747.72M | 0.65% |
UUP | -0.27% | $389.72M | 0.77% |
BUXX | -0.44% | $214.11M | 0.25% |
SHY | -0.49% | $23.07B | 0.15% |
BSCR | 0.54% | $2.89B | 0.1% |
BSSX | 0.61% | $69.62M | 0.18% |
VUSB | 0.69% | $4.35B | 0.1% |
CHIQ | 0.72% | $221.95M | 0.65% |
IBTI | 0.72% | $908.44M | 0.07% |
XHLF | 0.73% | $1.07B | 0.03% |
GCC | -0.76% | $142.85M | 0.55% |
CCOR | 0.79% | $71.02M | 1.18% |
SPSB | 0.82% | $8.72B | 0.04% |
VNLA | 0.84% | $2.32B | 0.23% |
FTSM | 0.84% | $6.21B | 0.45% |
PZA | 0.96% | $3.06B | 0.28% |
BCD | 1.03% | $251.68M | 0.3% |
USTB | 1.19% | $996.66M | 0.35% |
BSCQ | -1.19% | $4.25B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 46.94% | $50.86M | 0.69% |
RSPA | 45.50% | $274.60M | 0% |
EES | 39.79% | $662.16M | 0.38% |
GSSC | 39.78% | $561.84M | 0.2% |
IJT | 39.73% | $6.52B | 0.18% |
TPSC | 39.72% | $186.54M | 0.52% |
RZV | 39.60% | $226.89M | 0.35% |
XRT | 39.59% | $347.21M | 0.35% |
VIOO | 39.54% | $3.12B | 0.07% |
SLYG | 39.48% | $3.69B | 0.15% |
BSVO | 39.38% | $1.56B | 0.47% |
FYX | 39.35% | $960.72M | 0.6% |
ETH | 39.33% | $1.29B | 0% |
IWC | 39.30% | $956.01M | 0.6% |
RWJ | 39.24% | $1.80B | 0.39% |
SPSM | 39.19% | $12.70B | 0.03% |
EZET | 39.06% | $33.61M | 0% |
ETHA | 39.06% | $3.65B | 0.25% |
IWN | 39.06% | $12.18B | 0.24% |
IJR | 38.98% | $87.37B | 0.06% |
SeekingAlpha
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, and contract manufacturing. Read more here.
Finnhub
Guggenheim SMID Cap Biotech Conference February 5, 2025 © 2025 ANI...
Finnhub
PRINCETON, N.J., Jan. 28, 2025 -- ANI Pharmaceuticals, Inc. today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host a...
Finnhub
J.P. Morgan Healthcare Conference January 14, 2025 © 2025 ANI Pharmaceuticals,...
Finnhub
For full year 2024, the Company expects total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS to be at or above the guidance ranges provided on November 8, 2024Rare Disease...
SeekingAlpha
CG Oncology's stock has dropped 40% since its IPO peak, driven by profit-taking and competitive concerns despite promising Phase 3 data for Cretostimogene. Learn more on CGON stock here.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DV | -0.01% | $3.89B | -44.85% | 0.00% |
ORCL | 0.07% | $486.28B | +54.16% | 0.92% |
PHI | 0.09% | $5.00B | +0.30% | 7.31% |
REYN | -0.12% | $5.18B | -13.81% | 3.75% |
CATO | -0.16% | $72.29M | -49.71% | 14.29% |
OCX | -0.17% | $50.13M | -17.07% | 0.00% |
GILD | 0.18% | $132.05B | +44.42% | 2.91% |
MRK | 0.18% | $213.55B | -33.29% | 3.69% |
CYCN | 0.21% | $8.21M | +4.81% | 0.00% |
EQNR | 0.23% | $63.06B | -3.25% | 5.77% |
KRNT | 0.25% | $1.39B | +46.63% | 0.00% |
VZ | 0.26% | $172.76B | +1.11% | 6.52% |
ASPS | -0.29% | $31.31M | -59.51% | 0.00% |
FMTO | -0.29% | $31.91M | -99.39% | 0.00% |
HUYA | 0.31% | $281.45M | +67.26% | 0.00% |
BABA | 0.31% | $286.23B | +63.32% | 0.80% |
PSQH | -0.35% | $164.87M | -18.57% | 0.00% |
SUPN | 0.37% | $2.18B | +37.93% | 0.00% |
CASI | -0.40% | $34.71M | -56.62% | 0.00% |
CPNG | 0.40% | $44.97B | +58.63% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -25.97% | $195.31M | 0.85% |
BTAL | -22.80% | $277.56M | 1.43% |
TAIL | -21.27% | $62.82M | 0.59% |
ULST | -19.03% | $558.12M | 0.2% |
UNG | -12.79% | $739.12M | 1.06% |
DBE | -9.90% | $56.04M | 0.77% |
DBO | -8.15% | $191.98M | 0.77% |
OILK | -8.07% | $73.97M | 0.69% |
USL | -7.92% | $49.89M | 0.85% |
BNO | -7.91% | $94.01M | 1% |
USO | -7.59% | $1.12B | 0.6% |
KBA | -7.21% | $167.67M | 0.56% |
USCI | -7.07% | $215.20M | 1.07% |
ASHR | -6.98% | $2.27B | 0.65% |
UGA | -6.98% | $93.86M | 0.97% |
PDBC | -6.94% | $4.78B | 0.59% |
CNYA | -6.49% | $211.48M | 0.6% |
EQLS | -6.23% | $7.90M | 1% |
CTA | -6.12% | $681.78M | 0.76% |
XONE | -6.09% | $576.97M | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IOSP | 43.86% | $2.79B | -11.03% | 1.38% |
HLMN | 42.81% | $2.05B | +14.36% | 0.00% |
BCO | 41.57% | $4.09B | +13.26% | 1.03% |
MTRN | 41.18% | $2.06B | -27.88% | 0.53% |
KODK | 39.70% | $645.61M | +123.06% | 0.00% |
ZUMZ | 37.76% | $306.57M | -13.47% | 0.00% |
AVNT | 37.66% | $3.92B | +8.76% | 2.44% |
IMXI | 37.15% | $577.50M | -12.69% | 0.00% |
NWSA | 36.80% | $16.74B | +11.36% | 0.67% |
MBC | 36.64% | $2.11B | +8.62% | 0.00% |
GFF | 36.62% | $3.63B | +10.84% | 0.81% |
CBT | 36.55% | $4.65B | +2.41% | 1.95% |
VERX | 36.13% | $7.09B | +74.49% | 0.00% |
CDXS | 35.89% | $333.65M | +26.54% | 0.00% |
KRC | 35.70% | $4.18B | -1.56% | 6.03% |
VNO | 35.40% | $7.99B | +62.84% | 1.75% |
XHR | 35.13% | $1.47B | +7.31% | 3.32% |
TREX | 35.06% | $7.27B | -25.17% | 0.00% |
AXL | 34.78% | $558.51M | -44.44% | 0.00% |
ASH | 34.66% | $3.07B | -29.93% | 2.44% |